Digitally transforming the undiagnosed patient identification market for rare and genetic conditions

Welcome to ThinkGenetic

ThinkGenetic's goal is to speed time to diagnosis for genetic and rare conditions and reduce the chances of diagnostic error - two things that can make a significant difference for millions of people around the world. ThinkGenetic utilizes Natural Language Processing, statistical modeling, and proprietary algorithms to identify individuals at-risk of having a genetic disease. The ThinkGenetic experts have developed two validated solutions to identify at-risk patients: one through electronic health records, FindEHR, and the consumer-focused tool, SymptomMatcher.

Our validated products are sensitive and specific enough to flag patients at increased risk to have a genetic diagnosis and include targeted information to educate providers quickly and efficiently about available sponsored testing, enrolling clinical trials, referral to genetics, and FDA approved treatments. De-identified, HIPAA-compliant, summary data can then be shared with our pharma clients to supplement their sales and marketing efforts while benefiting the patients and assisting their clinicians to explore possible genetic diagnoses.

ThinkGenetic News

WORLDSymposium 2023

WORLDSymposium 2023

Published 02/08/2023

Chief Genetic Officer Dawn Laney to participate in Symposia panel on Phenotypic Variability for LSD. Learn More

Connect With Us

Ask a Question or Leave a Comment

Follow Us

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more about our use of cookies and similar technology

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me